Beaver Run Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology (C1)

Scientific Organizers: Mark Mercola, Fabien Vincent, Monica Schenone and Arsenio Nueda


March 3—7, 2019

Beaver Run Resort, Breckenridge, Colorado, USA


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 30, 2018 [details]
Discounted Abstract Deadline: Oct 30, 2018 [details]
Abstract Deadline: Dec 4, 2018 [details]
Discounted Registration Deadline: Jan 11, 2019 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-C1 "Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details		 Before and On October 30, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details		 After October 30, 2018 until December 4, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details		 October 30, 2018 n/a
Discounted NON-STUDENT Registration
More details		 Before and On January 11, 2019 845.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details		 After January 11, 2019 1045.00 USD
Discounted STUDENT Registration
More details		 Before and On January 11, 2019 620.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details		 After January 11, 2019 820.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.

Apply for a Scholarship



Discounted Abstract Deadline: October 30, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 4, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 30, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 30, 2018)

Discounted Registration Deadline: January 11, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 845.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 620.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1045.00 USD*
Student Registration Fee: 820.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, March 3 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 7 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 8 in order to fully experience the meeting.

SUNDAY, MARCH 3

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


MONDAY, MARCH 4

07:00—08:00
Breakfast

08:00—08:15
Welcoming Remarks (Organizers)

08:15—09:15
Keynote Address
Registered attendees can view abstracts starting on 02/03/2019
Big picture view of pharmaceutical development, challenges and new opportunities.

James E. Bradner, Novartis Institutes for BioMedical Research, USA
PDD, New Approach to Discovering Therapeutics

09:15—11:30
Clinical Success Stories
Registered attendees can view abstracts starting on 02/03/2019
Share success stories – newly approved drugs and late stage clinical candidates. Identify key lessons and best practices to inform future PDD projects.

Yoshihiro Watanabe, Kanazawa University, Japan
Discovery of JTP-74057/GSK1120212/Trametinib as a MEK-Inhibitor able to alter Phosphorylation State of MEK

Coffee Break

Fred Van Goor, Vertex Pharmaceuticals Incorporated, USA
Combonation Pharmacology to Treat the Underlying Cause of the Majority of People with Cystic Fibrosis

John Tallarico, Novartis Institutes of Biomedical Research, USA
Novel Therapies from Phenotypic Screening

Short Talk(s) Chosen from Abstracts

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop 1: Safety De-risking

* Fabien Vincent, Pfizer, USA

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
New Opportunities and Under-Represented Indications
Registered attendees can view abstracts starting on 02/03/2019
Illustrate new opportunities for PDD among hard to study and treat diseases. Illustrate new disease modeling technology that can be a breakthrough in finding drug targets and drugs.

Speaker to be Announced

Clemens R. Scherzer, Harvard Medical School, Brigham & Women's Hospital, USA
Turning Bits and Base Pairs into Precision Neurology

Scott S. Walker, Merck Research Laboratories, USA
Large-scale Antibacterial Phenotypic Screening and Systematic Hit Triage Reveal Novel Targets and Novel Inhibitors of Established Targets

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


TUESDAY, MARCH 5

07:00—08:00
Breakfast

08:00—11:00
Chemical Biology and Novel Molecular Mechanisms of Action
Registered attendees can view abstracts starting on 02/03/2019
Drugging targets considered traditionally undruggable. Small molecule probing of protein conformation/function.

Maurizio Pellecchia, University of California, Riverside, USA
NMR-based Fragment Screening for Oncology

Laura L. Kiessling, Massachusetts Institute of Technology, USA
Glycans in Health and Disease

Coffee Break

Razvan L. Cornea, University of Minnesota, USA
Targeting the Pathological Leak of a Calcium Channel for Heart Failure Therapeutics

Angela Koehler, Massachusetts Institute of Technology, USA
Chemical Probes of Transcription

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
Project Prosecution and Pre-clinical Advancement
Registered attendees can view abstracts starting on 02/03/2019
Addressing roadblocks in advancing drugs from phenotypic assays through pre-clinical development. Strategies for selecting high probability leads.

Arsenio Nueda, Almirall S.A., Spain
Harnessing the Power of Phenotypic Screening to Generate Novel Starting Points for Drug Discovery

Chun-wa Chung, GlaxoSmithKline, UK
Linking Differential Molecular Mode of Action to Distinct Pharmacology

Derek Lowe, Novartis Institutes for Biomedical Research, USA
Advancement of Phenotypic Hits

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


WEDNESDAY, MARCH 6

07:00—08:00
Breakfast

08:00—11:00
Physiologically Complex and Realistic Disease Assays
Registered attendees can view abstracts starting on 02/03/2019
Incorporating advances in stem cell disease modeling into drug discovery. Technological advances in complex and kinetic readouts. 3D organoids.

Rick Livesey, University of Cambridge, UK
Target Identification and Phenotypic Screening in Stem Cell Models of Alzheimer’s Disease

Randall T. Peterson, University of Utah, USA
Drug Discovery using Zebrafish

Coffee Break

Mark Mercola, Stanford University, USA
High Throughput Kinetic Imaging of iPSC-Derived Cardiomyocytes: Bringing the Patient to the Early Stages of Drug Discovery

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop 2: Clinical, Regulatory Case Studies with PDD Project Prosecution

* Marco Prunotto, F. Hoffmann-La Roche Ltd., Switzerland

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Functional Genomics and Systems Approaches
Registered attendees can view abstracts starting on 02/03/2019
Functional genomics, machine learning and data mining.

Speaker to be Announced

Thomas A. Wynn, Pfizer, USA
siRNA and CRISPR Screening in Primary Human Cells for Autoimmune and Fibrotic Diseases

Giulio Superti-Furga, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria
Systems Pharmacology as an Approach to Network Medicine

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 3


THURSDAY, MARCH 7

07:00—08:00
Breakfast

08:00—09:00
Keynote Address
Registered attendees can view abstracts starting on 02/03/2019

Benjamin F. Cravatt III, The Scripps Research Institute, USA
Activity-based Proteomics – Target and Ligand Discovery on a Global Scale

09:00—11:15
Compound Profiling and Repositioning
Registered attendees can view abstracts starting on 02/03/2019

Christopher A. Lipinski, Melior Discovery, Inc., USA
High Throughput in vivo Phenotypic Screening for Drug Repurposing: Discovery of MLR-1023 a Novel insulin Sensitizer and Novel Lyn Kinase Stimulant with Clinical Proof of Concept

Coffee Break

Marco Prunotto, F. Hoffmann-La Roche Ltd., Switzerland
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery

Umut Ozcan, Boston Children's Hospital, Harvard Medical School, USA
Withaferin A is a Leptin Sensitizer with Strong Antidiabetic Properties in Mice

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

16:30—17:00
Coffee Available

17:00—18:45
Target Identification / Deconvolution
Registered attendees can view abstracts starting on 02/03/2019

Dyann F. Wirth, Harvard School of Public Health, USA
Target ID for Malaria

Bridget Wagner, Broad Institute, USA
The Importance of Phenotypic Screening in Identifying New Targets for Disease Therapeutics

Herbert Waldmann, Max Planck Institute for Molecular Physiology, Germany
Chemotype - Phenotype - Target

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/03/2019

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


FRIDAY, MARCH 8

 
Departure


*Session Chair †Invited, not yet responded.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676